In a patient with epistaxis, what are the recommended initial management measures, indications for ordering imaging, and the appropriate imaging studies to obtain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Epistaxis and Imaging Indications

Imaging is not routinely indicated for epistaxis but should be obtained in patients with recurrent, severe, or posterior bleeding to detect underlying vascular lesions or tumors, with CT angiography being the preferred modality for vascular assessment and interventional planning 1.

Initial Management Measures

The immediate management of epistaxis follows a structured approach:

First-Line Interventions

  • Digital nasal compression: Lean forward and pinch the soft part of the nose for at least 5 minutes; if bleeding slows, continue for a full 15 minutes 2
  • Vasoconstrictor application: After blowing the nose to clear clots, spray oxymetazoline or phenylephrine (2 sprays in the bleeding nostril), then continue holding pressure for 5 minutes. May repeat once 2
  • Anterior rhinoscopy: Should be performed in all patients with epistaxis to identify the bleeding site and guide treatment 2

Risk Stratification

Identify high-risk factors that predict need for advanced intervention 2:

  • Prior nasal/sinus surgery
  • Nasal or facial trauma
  • Use of anticoagulation/antiplatelet medications
  • Personal or family history of bleeding disorders
  • Chronic kidney or liver disease
  • Nasal cannula oxygen or CPAP use

Indications for Imaging

The 2020 AAO-HNS guideline framework, supplemented by the 2026 European Society of Head and Neck Radiology recommendations, provides clear imaging indications:

When to Order Imaging

Imaging is indicated for 1:

  • Recurrent epistaxis despite prior treatment with packing or cautery
  • Severe or posterior bleeding
  • Recurrent unilateral nasal bleeding (concern for mass lesion)
  • Difficult-to-control epistaxis
  • Suspected underlying vascular malformation or tumor

Imaging is NOT routinely indicated for 1:

  • Simple anterior epistaxis controlled with conservative measures
  • First episode of self-limited bleeding
  • Bleeding controlled with anterior rhinoscopy and cautery

Specific Clinical Scenarios Requiring Imaging

Adolescent males with unilateral, profuse epistaxis: Examine posterior nasal cavity and nasopharynx for juvenile nasopharyngeal angiofibroma, which presents with epistaxis in 60-76% of cases 2

Unilateral symptoms: Nasal malignancies present with epistaxis in 55% of cases and may not be visible on anterior rhinoscopy 2

Children with unilateral epistaxis: Consider nasal foreign body (presents with epistaxis in 7% of cases); nasal endoscopy is preferred over imaging initially 2

Appropriate Imaging Studies

Primary Imaging Modality

CT angiography (CTA) is the preferred imaging study for epistaxis when imaging is indicated 1, 3:

  • Reveals the cause and location of hemorrhage
  • Identifies significant vessel variants and anatomic anomalies
  • Essential for pre-embolization planning
  • Assesses bony pathology and sinonasal anatomy

Complementary Imaging

CT of paranasal sinuses (non-contrast) 3:

  • Evaluates structural causes and anatomical variants
  • Preferred prior to surgical intervention
  • Assesses inflammatory or neoplastic disease

MRI 1:

  • Reserved for cases with suspected soft tissue pathology
  • When intracranial extension is suspected
  • Complements CT for tumor characterization

Clinical Algorithm for Imaging Decision

  1. Initial presentation with active bleeding: No imaging; proceed with anterior rhinoscopy and conservative management 2, 1

  2. Bleeding controlled but recurrent despite cautery/packing: Perform or refer for nasal endoscopy first 2; if endoscopy inconclusive or shows concerning findings, obtain CTA 1

  3. Severe posterior bleeding requiring intervention: Obtain CTA before embolization 3

  4. Unilateral recurrent bleeding: Nasal endoscopy mandatory 2; if mass suspected, obtain CT ± MRI 1

  5. Failed conservative and surgical management: CTA for embolization planning 3, 4

Common Pitfalls

Ordering imaging too early: Most epistaxis (87% anterior) resolves with conservative measures and does not require imaging 5. Imaging should be reserved for the specific indications above to avoid unnecessary cost and radiation exposure.

Skipping nasal endoscopy: Endoscopy should precede imaging in recurrent cases, as it may identify the bleeding source or pathology without radiation exposure 2.

Wrong imaging modality: Non-contrast CT has limited utility in active bleeding scenarios; CTA is superior for identifying vascular sources and planning intervention 1, 3.

Delaying imaging in high-risk presentations: Adolescent males with unilateral profuse bleeding or adults with unilateral recurrent bleeding require prompt endoscopy and imaging to exclude life-threatening lesions like juvenile angiofibroma or malignancy 2.

References

Guideline

clinical practice guideline: nosebleed (epistaxis).

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

Research

Posterior epistaxis management: review of the literature and proposed guidelines of the hellenic rhinological-facial plastic surgery society.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2024

Research

Clinical Study and Management of Epistaxis.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.